Stefan Kudlacek Selected Research

Estrogens (Estrogen)

9/2012	[Osteoporosis in men receiving androgen deprivation therapy for non-metastatic prostate cancer].
10/2011	Influence of age and gender on associations of body mass index with bone mineral density, bone turnover markers and circulating calcium-regulating and bone-active sex hormones.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Kudlacek Research Topics

Disease

5	Osteoporosis 11/2012 - 09/2005
3	Bone Resorption 10/2011 - 09/2005
3	Neoplasms (Cancer) 01/2007 - 09/2005
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017 - 01/2007
2	Vitamin D Deficiency 01/2014 - 09/2002
2	Prostatic Neoplasms (Prostate Cancer) 09/2012 - 01/2007
2	Peripheral Arterial Disease 09/2005 - 09/2002
1	Dermatomyositis (Dermatopolymyositis) 02/2021
1	Persistent Vegetative State (Vegetative State) 01/2014
1	Postmenopausal Osteoporosis 09/2012
1	Hyperthyroidism 01/2008
1	Thyroid Neoplasms (Thyroid Cancer) 01/2008
1	Metabolic Bone Diseases (Osteopenia) 01/2008
1	Bone Diseases (Bone Disease) 01/2007
1	Neoplasm Metastasis (Metastasis) 01/2007
1	Hypercalcemia (Milk Alkali Syndrome) 09/2005
1	Pain (Aches) 03/2005
1	Lactose Intolerance (Intolerance, Lactose) 01/2002

Drug/Important Bio-Agent (IBA)

3	CalciumIBA 01/2014 - 09/2005
3	Biomarkers (Surrogate Marker)IBA 01/2014 - 01/2007
3	Vitamin D FDA LinkGeneric 10/2011 - 09/2002
2	Gemcitabine FDA Link 01/2017 - 01/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 01/2007
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2017 - 01/2007
2	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 01/2007
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 01/2007
2	Diphosphonates (Bisphosphonates)IBA 09/2012 - 09/2005
2	AndrogensIBA 09/2012 - 01/2007
2	RANK LigandIBA 09/2012 - 09/2012
2	Monoclonal AntibodiesIBA 09/2012 - 09/2012
2	Denosumab FDA Link 09/2012 - 09/2012
2	Estrogens (Estrogen)FDA Link 09/2012 - 10/2011
2	glutamyl- lysyl- alanyl- histidyl- aspartyl- glycyl- glycyl- arginineIBA 10/2011 - 03/2005
2	Parathyroid Hormone (Parathormone)IBA 10/2011 - 03/2005
2	OsteoprotegerinIBA 09/2005 - 09/2005
1	MyostatinIBA 02/2021
1	Selective Estrogen Receptor Modulators (SERM)IBA 09/2012
1	Toremifene (Fareston)FDA Link 09/2012
1	Testosterone (Sustanon)FDA Link 10/2011
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2008
1	Cathepsin KIBA 01/2008
1	Thyroid HormonesIBA 01/2008
1	Docetaxel (Taxotere)FDA Link 01/2007
1	Hormones (Hormone)IBA 01/2007
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2005
1	hydroxide ionIBA 03/2005
1	Alkaline PhosphataseIBA 03/2005
1	OsteocalcinIBA 03/2005
1	HydrogenIBA 01/2002
1	Lactose FDA LinkGeneric 01/2002

Therapy/Procedure

6	Therapeutics 11/2012 - 01/2007
1	Neoadjuvant Therapy 01/2017
1	Drug Therapy (Chemotherapy) 01/2007
1	Prostatectomy (Retropubic Prostatectomy) 01/2007
1	Radiotherapy 01/2007